放射性药物

预约门诊
打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究此手术的领域

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 查找姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 查找姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 主动 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 查找姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: P

  1. Annie T. Packard, M.D.

    Annie T. Packard, M.D.

    1. Rochester, MN
    擅长领域：

    Kidney biopsy, Radiopharmaceutical therapy

研究

妙佑医疗国际的医生和科学家正在研究新型放射性药物，以改进多种疾病和状况的诊断和治疗。

放射性药物疗法是癌症研究的一个活跃领域。这些研究系与妙佑医疗国际综合癌症中心合作开展。美国国家癌症研究所为妙佑医疗国际综合癌症中心提供资助并将其指定为综合癌症中心。这是对该中心在癌症预防、诊断和治疗方面的卓越科学成就和多学科资源的认可。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在放射性药物疗法领域的著述目录。

Research Profiles

编辑搜索过滤条件
close

缩小搜索范围

查看所有医生 • 所有位置

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
Dec. 31, 2025
打印
  1. General nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/gennuclear. Accessed June 25, 2025.
  2. What is nuclear medicine and molecular imaging? Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/What-is-Nuclear-Medicine-and-Molecular-Imaging.aspx. Accessed June 25, 2025.
  3. About nuclear medicine and molecular imaging. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Web/About/About-Nuclear-Medicine-and-Medical-Imaging. Accessed June 25, 2025.
  4. Lapi SE, et al. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology. The Lancet Oncology. 2024; doi:10.1016/S1470-2045(24)00030-5.
  5. O'Malley JP, et al., eds. Nuclear Medicine and Molecular Imaging: The Requisites. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed May 13, 2025.
  6. Mititelu MR, et al. Overview of adverse reactions of radiopharmaceuticals. Clinical Oncology. 2025; doi:10.1016/j.clon.2025.103857.
  7. Bone scan. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/bone-scan. Accessed June 25, 2025.
  8. Hepatobiliary nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/hepatobiliary. Accessed June 25, 2025.
  9. Scintimammography. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/scintimammo. Accessed June 25, 2025.
  10. Townsend CM Jr, et al. The parathyroid glands. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed July 11, 2025.
  11. Pylarify (prescribing information). Progenics Pharmaceuticals; 2023. https://www.pylarify.com. Accessed July 11, 2025.
  12. Kit for the preparation of technetium Tc 99m mertiatide injection (prescribing information). Jubilant Radiopharma; 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216820. Accessed July 11, 2025.
  13. Fact sheet: Molecular imaging and the brain. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Molecular-Imaging-and-the-Brain.aspx. Accessed June 25, 2025.
  14. Lymphoscintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/lympho. Accessed June 25, 2025.
  15. Thyroid scan and uptake. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/thyroiduptake. Accessed June 25, 2025.
  16. Zevalin (prescribing information). Spectrum Pharmaceuticals; 2018. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=125019. Accessed July 8, 2025.
  17. Lutathera (prescribing information). Novartis; 2024. https://www.lutathera.com. Accessed July 8, 2025.
  18. Pluvicto (prescribing information). Novartis; 2025. https://www.pluvicto.com. Accessed July 8, 2025.
  19. Metastron (prescribing information). GE Healthcare; 2013. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020134. Accessed July 8, 2025.
  20. Metastron (prescribing information). Bayer; 2019. https://www.xofigo.com. Accessed July 8, 2025.
  21. Patient preparation for nuclear medicine procedures involving injections. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Nuclear-Medicine-101.aspx. Accessed June 25, 2025.
  22. Renal (kidney) scintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/renal. Accessed June 25, 2025.
  23. Radioactive iodine (I-131) therapy for hyperthyroidism. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radioiodine. Accessed June 25, 2025.
  24. Hicon (prescribing information). Jubilant Radiopharma; 2021. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021305. Accessed July 8, 2025.
  25. Nuclear medicine and radiation safety. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Fact-Sheet--Nuclear-Medicine-and-Radiation-Safety.aspx. Accessed June 25, 2025.
  26. Cardiac nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/cardinuclear. Accessed June 25, 2025.
  27. Health Education & Content Services. Radioactive iodine (I-131). Mayo Clinic; 2018.
  28. Health Education & Content Services. Prostate-specific membrane antigen therapy: For the treatment of prostate cancer. Mayo Clinic; 2023.
  29. Health Education & Content Services. Radioligand therapy for somatostatin-positive tumors. Mayo Clinic; 2024.
  30. Radioimmunotherapy (RIT). RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radio-immuno. Accessed June 25, 2025.
  31. Calais J, et al. Best patient care practices for administering PSMA-targeted radiopharmaceutical therapy. Journal of Nuclear Medicine. 2024; doi:10.2967/jnumed.124.268363.
  32. All about your radiology report: What to know. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/all-about-your-radiology-report. Accessed July 9, 2025.
  33. Catalano OA, ed. Radiopharmaceuticals and contrast agents. In: Clinical PET/MRI. Elsevier; 2023. https://www.clinicalkey.com. Accessed May 13, 2025.
  34. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  35. Choline C 11 injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025.
  36. Become a comprehensive radiopharmaceutical therapy center of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence/Become-a-Comprehensive-Radiopharmaceutical-Therapy-Center-of-Excellence.aspx. Accessed July 29, 2025.
  37. Medical review (expert opinion). Mayo Clinic. July 26, 2025.

相关

Mayo Clinic 新闻

放射性药物